![]() |
市场调查报告书
商品编码
1722534
2025 年至 2033 年骨骼生长刺激器市场报告(按产品、应用、最终用户和地区)Bone Growth Stimulator Market Report by Product, Application, End User, and Region 2025-2033 |
2024 年全球骨骼生长刺激器市场规模达 22 亿美元。展望未来, IMARC Group预计到 2033 年市场规模将达到 34 亿美元,2025-2033 年期间的成长率 (CAGR) 为 4.8%。由于事故、运动伤害和年龄相关因素导致的骨折发生率不断上升、用户友好型设备的不断发展以及对非侵入性治疗方案的偏好日益增加,市场正在经历稳定的增长。
主要市场驱动因素:根据骨骼生长刺激器市场前景,关键驱动因素包括运动相关损伤的增加、对加速骨骼癒合和缩短恢復时间的好处的认识,以及快速的技术进步,例如电磁和超音波刺激器的发展。
主要市场趋势:根据骨骼生长刺激器市场统计数据,值得注意的趋势包括向非侵入性治疗的持续转变、对便携式、用户友好型设备的需求不断增长以及再生医学的持续进步。
地理趋势:受完善的医疗保健基础设施的推动,北美引领市场。然而,由于患者越来越关注强化治疗方案,亚太地区正成为一个快速成长的市场。
竞争格局:骨骼生长刺激器产业的主要市场参与者包括 Arthrex Inc.、DJO Global Inc.、Elizur Corporation、IGEA SpA、Isto Biologics、Ito Co. Ltd.、Medical Device Business Services Inc. (Johnson & Johnson)、Medtronic Plc、Orthofix Medical Inc.、Ossatec Corporation Inc. (Johnson & Johnson)、Medtronic Plc、Orthofix Medical Inc.、Ossatec Corporation Benelctux B.Sker.
挑战与机会:根据骨骼生长刺激器市场概况,市场面临挑战,例如需要持续的研究验证。它还面临着开发更先进、更具成本效益的设备的机会。
骨折发生率上升
由于个人骨折发生率的上升,骨骼生长刺激器的采用率不断提高,这对骨骼生长刺激器的使用产生了积极影响。与此一致,骨折可能由于各种原因发生,例如事故、运动伤害和年龄相关因素。根据世界卫生组织 (WHO) 的数据,每年有 2,000 万至 5,000 万人在道路交通事故中遭受非致命伤害,导致骨折和损伤,需要有效的治疗。此外,由于老年人由于骨密度降低而更容易出现骨折问题,因此老年族群中骨骼生长刺激器的使用率不断上升,这也推动了市场的成长。除此之外,骨骼生长刺激器为更快、更有效的骨骼癒合提供了可行的解决方案,使其成为医疗保健专业人员和患者的首选。此外,患者对增强治疗方案的关注度不断提高,也推动了骨骼生长刺激器市场的发展。此外,人们越来越喜欢骨骼生长刺激器,因为与传统的骨折治疗相比,它们有助于更快地恢復并减轻疼痛。
技术进步
技术进步有助于开发更先进、更有效率、更用户友善的设备,进而促进市场成长。此外,越来越多地使用结合电磁场、超音波和脉衝电磁场 (PEMF) 等先进技术的骨骼生长刺激器来刺激骨骼再生,有利于市场成长。除此之外,改进的设备设计和功能不仅可以提高治疗效果,还可以提高患者的依从性。此外,由于患者可以将其融入日常生活中,小型、便携且具有先进控制功能的设备越来越多地被采用,从而支撑了骨骼生长模拟器的市场份额。与此相符的是,医疗保健提供者正在为他们的患者寻求有效且基于证据的解决方案。此外,大众对更有效、更有吸引力的治疗方案的需求不断增长,推动了市场的成长。此外,配备无线连接的先进骨骼生长刺激器的引入,使医疗保健提供者能够远端监控患者的依从性和治疗进展。例如,Orthofix Medical Inc 宣布美国 FDA 批准行动应用程式版本 2.1 STIMonTrack 以推进骨骼生长刺激器的发展。
非侵入性治疗方案的偏好日益增加
患者对非侵入性和无痛治疗方案的需求不断增加,这对骨骼生长刺激器市场收入产生了积极推动作用。与此相符的是,患者越来越多地寻求手术和侵入性手术的替代方案。此外,骨骼生长刺激器为骨骼癒合提供了非手术选择。此外,非侵入性治疗不仅可以减轻患者的不适,还可以最大限度地降低併发症和感染的风险。这使得骨骼生长刺激器对广大患者特别有吸引力,包括那些对手术犹豫不决或对侵入性手术有禁忌症的患者。除此之外,非侵入性治疗通常可以缩短恢復时间,使患者能够更快地恢復日常活动。此外,对以患者为中心的方法的日益关注也促进了市场的成长。此外,与外科手术相比,非侵入性治疗更具成本效益,因为它们需要更少的医院资源、更短的住院时间并降低整体医疗保健费用,这对骨骼生长刺激器市场价格产生积极影响。
骨骼生长刺激装置占大部分市场份额
根据以产品为基础的骨骼生长刺激器市场细分,骨骼生长刺激装置占有最大的份额。它们是旨在促进骨骼自然癒合的非侵入性医疗器材。它们的工作原理是将特定类型的能量(例如电磁场、超音波或电流)传送到骨骼损伤或骨折部位。与此一致,这些设备通常具有多种形式,例如可穿戴支架、便携式装置或可植入装置。设备的选择取决于骨折的性质和位置。它们加速成骨细胞等骨形成细胞的产生,帮助修復和再生受损的骨组织。
脊椎融合手术占据行业最大份额
根据骨骼生长刺激器市场趋势,脊椎融合手术占据最大的市场份额。它们涉及连接脊椎中的两个或多个椎骨,以治疗脊椎不稳定、退化性椎间盘疾病或脊椎骨折等疾病。在脊椎融合中,骨骼生长刺激器在促进融合过程中发挥关键作用。它们刺激手术部位的骨骼癒合,帮助椎骨更有效、更安全地融合在一起。脊椎相关疾病的增加以及对改善手术效果的需求不断增长,对骨骼生长刺激器的未来产生了积极影响。
医院和诊所是主要的细分市场
根据骨骼生长刺激器市场细分,医院和诊所经常在各种应用中使用骨骼生长刺激器,包括骨科手术、骨折管理和术后护理。在医院中,这些刺激器被骨科医生和物理治疗部门用来帮助治疗骨折、脊椎融合手术和其他骨科疾病。医院和诊所的机构设置确保患者在使用骨骼生长刺激器期间得到专家的照顾和指导。
北美引领市场,占据最大的骨骼生长刺激器市场份额
该报告还对所有主要区域市场进行了全面的分析,包括北美(美国和加拿大);欧洲(德国、法国、英国、义大利、西班牙、俄罗斯等);亚太地区(中国、日本、印度、韩国、澳洲、印尼等);拉丁美洲(巴西、墨西哥等);以及中东和非洲。根据报告,北美是骨骼生长刺激剂最大的区域市场。
根据骨骼生长刺激器市场趋势,北美由于拥有完善的医疗保健基础设施(如医院和诊所)占据了最大的市场份额。同时,主要参与者正在开发先进的骨骼生长刺激器设备,以促进该地区市场的成长。此外,为确保提高安全性和有效性,医疗器材的严格监管架构正在推动市场成长。
市场研究报告也对市场竞争格局进行了全面的分析。也提供了所有主要公司的详细资料。骨骼生长刺激器产业的主要市场参与者包括 Arthrex Inc.、DJO Global Inc.、Elizur Corporation、IGEA SpA、Isto Biologics、Ito Co. Ltd.、Medical Device Business Services Inc. (Johnson & Johnson)、Medtronic Plc、Orthofix Medical Inc.、Ossatec Benelux BV、Stry Bimmerel.
(请注意,这只是关键参与者的部分列表,完整列表在报告中提供。)
最近的报告分析了骨骼生长刺激器市场的规模,强调该行业的主要参与者正专注于透过结合先进技术、改进设备设计和提高治疗效果来开发先进的骨骼生长刺激器设备。为此,各公司正在进行临床试验,以证明其产品的安全性和有效性。此外,他们正在扩大其产品组合,提供一系列骨骼生长刺激器选项,例如根据特定应用量身定制的设备,包括脊椎融合或骨折癒合,对骨骼生长刺激器市场价格产生积极影响。除此之外,製造商也与医疗机构、研究组织和学术机构合作,促进骨骼生长刺激器技术的研究、开发和验证。此外,他们正在与监管机构密切合作,以获得其设备的批准和认证。
2020 年 2 月 13 日:专注于肌肉骨骼产品和疗法的全球医疗器材公司 Orthofix Medical Inc. 宣布,美国食品药物管理局 (FDA) 批准将 STIM onTrack 行动应用程式 2.1 版与该公司的骨骼生长刺激器一起使用。行动装置应用程式是一款旨在帮助患者遵守处方并改善临床结果的配件。
2020 年 1 月 8 日:美敦力公司收购了位于伊利诺伊州布卢明顿的私人控股公司 Stimgenics, LLC,该公司率先推出了一种称为差异靶多路復用 (DTM(TM)) 脊髓刺激的新型脊髓刺激 (SCS) 波形。该疗法透过美敦力 Intellis 平台提供,是一种治疗慢性疼痛患者的全新独特的程式选项。
2021 年 5 月 17 日:IGEA SpA 与 Orthofix Medical Inc. 签署独家授权协议,以在海外商业化一系列专用于刺激的创新产品。此外,骨骼生长刺激和关节保护装置将在美国和加拿大商业化。
The global bone growth stimulator market size reached USD 2.2 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.4 Billion by 2033, exhibiting a growth rate (CAGR) of 4.8% during 2025-2033. The market is experiencing stable growth driven by the growing incidences of bone fractures due to accidents, sports injuries, and age-related factors, rising development of user-friendly devices, and increasing preferences for non-invasive treatment solutions.
Major Market Drivers: According to the bone growth stimulator market outlook, key drivers include the rising sports-related injuries, awareness about the benefits of accelerated bone healing and reduced recovery time, and rapid technological advancements, such as the development of electromagnetic and ultrasound-based stimulators.
Key Market Trends: Based on the bone growth stimulator market statistics, notable trends include the ongoing shift towards non-invasive treatments, growing demand for portable, user-friendly devices, and ongoing advancements in regenerative medicine.
Geographical Trends: North America leads the market, driven by the presence of well-established healthcare infrastructure. However, Asia Pacific is emerging as a fast-growing market due to the increasing focus on enhanced treatment solutions among patients.
Competitive Landscape: Some of the major market players in the bone growth stimulator industry include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), and Zimmer Biomet, among many others.
Challenges and Opportunities: As per the bone growth stimulator market overview, the market faces challenges, such as the need for continuous research validation. It also encounters opportunities in developing more advanced and cost-effective devices.
Rising incidences of bone fractures
The growing adoption of bone growth stimulators due to rising incidences of bone fractures among individuals is positively impacting the uses of bone growth stimulator. In line with this, bone fractures can occur due to various reasons, such as accidents, sports injuries, and age-related factors. According to the World Health Organization (WHO), between 20 and 50 million people suffer non-fatal injuries in road accidents, leading to fracturs and injuries that require effective treatment options. Moreover, the rising employment of bone growth stimulators among the geriatric population, as they are more prone to fracture issues due to reduced bone density, is propelling the growth of the market. Apart from this, bone growth stimulators offer a viable solution for quicker and more effective bone healing, making them a preferred choice among healthcare professionals and patients. In addition, the increasing focus on enhanced treatment solutions among patients is impelling the bone growth stimulator market opportunities. Furthermore, people are increasingly preferring bone growth stimulators, as they assist in faster recovery and reduced pain as compared to traditional fracture treatments.
Technological advancements
Technological advancements assist in the development of more advanced, efficient, and user-friendly devices, which is contributing to the market growth. In addition, the increasing use of bone growth stimulators that incorporate advanced technologies, such as electromagnetic fields, ultrasound, and pulsed electromagnetic fields (PEMF), to stimulate bone regeneration, is favoring the market growth. Apart from this, improved device design and functionality not only enhance treatment outcomes but also improve patient compliance. Furthermore, the rising adoption of smaller and portable devices with advanced control, as they allow patients to incorporate them into their daily routines, is supporting the bone growth simulator market share. In line with this, healthcare providers are seeking effective and evidence-based solutions for their patients. Additionally, the increasing demand for more effective and appealing treatment options among the masses is propelling the market growth. Moreover, the introduction of advanced bone growth stimulators that are equipped with wireless connectivity, enables healthcare providers to monitor patient compliance and treatment progress remotely. For instance, Orthofix Medical Inc announced U.S. FDA approval of mobile app version 2.1 STIMonTrack to advance bone growth stimulators.
Increasing preferences for non-invasive treatment solutions
The increasing demand for non-invasive and painless treatment options among patients is positively impelling the bone growth stimulator market revenue. In line with this, patients are increasingly seeking alternatives to surgery and invasive procedures. Additionally, bone growth stimulators provide a non-surgical option for bone healing. Furthermore, non-invasive treatments not only reduce patient discomfort but also minimize the risk of complications and infection. This makes bone growth stimulators particularly appealing to a broad spectrum of patients, including those who are hesitant about surgery or have contraindications for invasive procedures. Apart from this, non-invasive treatments often lead to shorter recovery times, allowing patients to resume their daily activities more quickly. Moreover, the rising focus on patient-centric approaches is bolstering the market growth. In addition, non-invasive treatments are more cost-effective as compared to surgical procedures, as they require fewer hospital resources, shorter hospital stays, and reduce overall healthcare expenses, which is positively influencing the bone growth stimulator market price.
Bone growth stimulation devices accounts for the majority of the market share
According to the bone growth stimulator market segment based on the product, bone growth stimulation devices hold the largest share. They are non-invasive medical instruments designed to promote the natural healing of bones. They work by delivering specific types of energy, such as electromagnetic fields, ultrasound waves, or electrical currents, to the site of the bone injury or fracture. In line with this, these devices are usually available in various forms, such as wearable braces, portable units, or implantable options. The choice of device depends on the nature and location of the fracture. They accelerate the production of bone-forming cells, such as osteoblasts, aiding in the repair and regeneration of damaged bone tissues.
Spinal fusion surgeries hold the largest share of the industry
According to the bone growth stimulator market trends, spinal fusion surgeries represented the largest market share. They involve joining two or more vertebrae in the spine to treat conditions like spinal instability, degenerative disc disease, or spinal fractures. In spinal fusion, bone growth stimulators play a critical role in promoting the fusion process. They stimulate bone healing at the surgical site, helping the vertebrae to fuse together more effectively and securely. The growing number of spinal-related conditions, along with the rising need for improved surgical outcomes, is positively impacting the future of bone growth stimulators.
Hospitals and clinics represent the leading market segment
As per the bone growth stimulator market segments, hospitals and clinics often use bone growth stimulators in various applications, including orthopedic surgeries, fracture management, and post-operative care. In hospitals, these stimulators are employed by orthopedic surgeons and in physical therapy departments to aid in the healing of bone fractures, spinal fusion procedures, and other orthopedic conditions. The institutional setting of hospitals and clinics ensures that patients receive expert care and guidance during the use of bone growth stimulators.
North America leads the market, accounting for the largest bone growth stimulator market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for bone growth stimulator.
According to the bone growth stimulator market trends, North America accounted for the largest market share due to the presence of well-established healthcare infrastructure, such as hospitals and clinics. In line with this, key players are developing advanced bone growth stimulator devices, which are bolstering the growth of the market in the region. Moreover, stringent regulatory frameworks for medical devices to ensure enhanced safety and efficacy are propelling the market growth.
The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the bone growth stimulator industry include Arthrex Inc., DJO Global Inc., Elizur Corporation, IGEA S.p.A., Isto Biologics, Ito Co. Ltd., Medical Device Business Services Inc. (Johnson & Johnson), Medtronic Plc, Orthofix Medical Inc., Ossatec Benelux B.V., Stryker Corporation, Terumo Bct Inc. (Terumo Corporation), Zimmer Biomet, etc.
(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)
Recent reports analyzing how big is the bone growth stimulator market highlighted that key players in the industry are focusing on developing advanced bone growth stimulator devices by incorporating advanced technologies, improving device design, and enhancing treatment efficacy. In line with this, companies are conducting clinical trials to demonstrate the safety and effectiveness of their products. Moreover, they are expanding their product portfolios to offer a range of bone growth stimulator options, such as devices tailored as per specific applications, including spinal fusion or fracture healing, positively impacting the bone growth stimulator market price. Apart from this, manufacturers are collaborating with healthcare institutions, research organizations, and academic institutions to facilitate research, development, and the validation of bone growth stimulator technologies. Furthermore, they are working closely with regulatory authorities to obtain approvals and certifications for their devices.
February 13, 2020: Orthofix Medical Inc., a global medical device company focused on musculoskeletal products and therapies, announced that the U.S. Food and Drug Administration (FDA) approved the use of STIM onTrack mobile app version 2.1 with the bone growth stimulators of the company. The mobile device app is an accessory designed to help patients adhere to their prescriptions and improve their clinical outcomes.
January 8, 2020: Medtronic Plc acquired Stimgenics, LLC, a privately-held company based in Bloomington, Illinois, that has pioneered a novel spinal cord stimulation (SCS) waveform known as Differential Target Multiplexed (DTM(TM)) spinal cord stimulation. The therapy, which is delivered via the Medtronic Intellis platform, is a new and unique programming option to treat patients with chronic pain.
May 17, 2021: IGEA S.p.A. signed an exclusive license agreement with Orthofix Medical Inc. to commercialize overseas the range of innovative products dedicated to stimulation. In addition, the bone growth stimulation and joint preservation devices will be commercialized in the United States and Canada.